Form 4 for DAR DARLING INGREDIENTS INC.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001193125-26-100382 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-10 | 2026-03-06 | DAR | STUEWE RANDALL C | COB, CEO, Dir | M - OptEx | $11.97 | +263.7K | 1.28M | +26% | +$3.16M |
| DM | 2026-03-10 | 2026-03-06+ | DAR | STUEWE RANDALL C | COB, CEO, Dir | F - Tax | $52.94 | -175.2K | 1.14M | -13% | -$9.28M |
| D | 2026-03-10 | 2026-03-09 | DAR | STUEWE RANDALL C | COB, CEO, Dir | A - Grant | $0.00 | +90.1K | 1.18M | +8% | $0 |
| D | 2026-03-10 | 2026-03-06 | DAR | STUEWE RANDALL C | COB, CEO, Dir | G - Gift | $0.00 | -23.2K | 1.09M | -2% | $0 |
| D | 2026-03-10 | 2026-03-06 | DAR | STUEWE RANDALL C | COB, CEO, Dir | S - Sale+OE | $52.12 | -20.0K | 1.12M | -2% | -$1.04M |
| D | 2026-03-10 | 2026-03-06 | DAR | STUEWE RANDALL C | COB, CEO, Dir | M - OptEx | $0.00 | -263.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | M | A | 263,704 | $11.97 | 1,276,839 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-09 | F | D | 35,446 | $51.92 | 1,148,467 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-09 | A | A | 90,078 | $0.00 | 1,183,913 | D | — | — | (F3) Shares of common stock received by the reporting person upon vesting of performance shares related to the performance period from 2023 - 2025. |
| 4 | Common | Common Stock | 2026-03-06 | G | D | 23,250 | $0.00 | 1,093,835 | D | — | — | (F2) On 03/06/2026, the reporting person donated 23,250 shares of directly owned shares of common stock to a public university in the United States. |
| 5 | Common | Common Stock | 2026-03-06 | S | D | 20,000 | $52.12 | 1,117,085 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $52.03 to $53.28; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. |
| 6 | Common | Common Stock | 2026-03-06 | F | D | 139,754 | $53.20 | 1,137,085 | D | — | — | |
| 7 | Derivative | Options (right to buy) | 2026-03-06 | M | D | 263,704 | $0.00 | 0 | D | $11.97 · — to 2026-03-07 | 263,704 Common Stock | (F4) Options granted pursuant to the 2012 Omnibus Incentive Plan to purchase 42,690 shares became exercisable on 03/07/16, 73,672 became exercisable on 03/07/17 and 73,671 shares became exercisable on each of 03/07/18 and 03/07/19. |